Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Choosing a wide market index fund for retirement involves evaluating diversification, costs, and alignment with your time horizon.
28,206 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As Bitcoin prices turned volatile, Strategy—formerly MicroStrategy—pushed a high-stakes financing strategy that boost...
ETF inflows rebound for crypto funds, but XRP fails to breakout as Ripple expands globally and markets digest regulat...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
A focused screen uncovers a small group of high-yielding stocks trading double-digit discounts, offering both steady ...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
Apple appears to have sealed an early victory in the 2026 chip race, securing dominant access to the most advanced pr...
Investors are watching the Fed for its next move, a key factor in whether GLD can extend its recent 36% rally. Real y...
Agricultural commodities offer a unique path to diversification and inflation protection. This guide breaks down how ...
Canopy Growth has seen dramatic swings, trading under $2 after years of highs. This guide breaks down what could push...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...
Discover what Universal (UVV) 2026 earnings mean for investors. This plain-English guide breaks down performance driv...